Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Women 4 Oncology: Advancing the careers of female oncologists

Dr Solange Peters - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Women 4 Oncology: Advancing the careers of female oncologists ( Dr Solange Peters - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland )
22 Oct 2018

Cisplatin superior to cetuximab for HPV oropharyngeal cancer

Prof Hisham Mehanna - University of Birmingham , Birmingham, UK
Cisplatin superior to cetuximab for HPV oropharyngeal cancer ( Prof Hisham Mehanna - University of Birmingham , Birmingham, UK )
22 Oct 2018

Cisplatin v cetuximab for HPV associated oropharyngeal cancer

Prof Hisham Mehanna - University of Birmingham , Birmingham, UK
Cisplatin v cetuximab for HPV associated oropharyngeal cancer ( Prof Hisham Mehanna - University of Birmingham , Birmingham, UK )
22 Oct 2018

ESMO 2018: Melanoma highlights

Dr Teresa Amaral, Will Davies
ESMO 2018: Melanoma highlights ( Dr Teresa Amaral, Will Davies )
22 Oct 2018

Assessing radiotherapy for men with newly diagnosed metastatic prostate cancer

Dr Chris C. Parker - The Royal Marsden, London, UK
Assessing radiotherapy for men with newly diagnosed metastatic prostate cancer ( Dr Chris C. Parker - The Royal Marsden, London, UK )
22 Oct 2018

IMpower130: PFS and safety of adding atezolizumab to first-line NSCLC therapy

Dr Federico Cappuzzo - AUSL della Romagna-Ravenna, Ravenna, Italy
IMpower130: PFS and safety of adding atezolizumab to first-line NSCLC therapy ( Dr Federico Cappuzzo - AUSL della Romagna-Ravenna, Ravenna, Italy )
22 Oct 2018

KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma

Prof Barbara Burtness - Yale Cancer Center, New Haven, USA
KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma ( Prof Barbara Burtness - Yale Cancer Center, New Haven, USA )
22 Oct 2018

ESMO 2018: Highlights

Prof Gordon McVie , Will Davies
ESMO 2018: Highlights ( Prof Gordon McVie , Will Davies )
22 Oct 2018

IMpassion 130 trial results: Immunotherapy for metastatic breast cancer

Prof Peter Schmid - St Bartholomew Hospital London, UK
IMpassion 130 trial results: Immunotherapy for metastatic breast cancer ( Prof Peter Schmid - St Bartholomew Hospital London, UK )
22 Oct 2018

The TRIBE-2 study for colorectal cancer

Dr Chiara Cremolini - Università di Pisa, Pisa, Italy
The TRIBE-2 study for colorectal cancer ( Dr Chiara Cremolini - Università di Pisa, Pisa, Italy )
22 Oct 2018

Advances in metastatic non small cell lung cancer

Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany
Advances in metastatic non small cell lung cancer ( Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )
21 Oct 2018

Detecting copy number alterations using a pre-natal test

Dr Liesbeth Lenaerts - KU Leuven, Leuven, Belgium
Detecting copy number alterations using a pre-natal test ( Dr Liesbeth Lenaerts - KU Leuven, Leuven, Belgium )
21 Oct 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation